Ā | Overall survival | Disease-free survival | Breast cancer recurrence in the axilla | Ā |
---|---|---|---|---|
AMAROS | ALND: 71/744 aRT: 76/681; 5-year: ALND: 93.3Ā % (95Ā % CI 91ā95); aRT: 92.5Ā % (95Ā % CI 90ā94.4); HRĀ =Ā 1.17 (95Ā % CI 0.85ā1.62), pĀ =Ā 0.34 | ALND: 124/744 aRT: 134/681; 5-year: ALND: 86.9Ā % (95Ā % CI 84.1ā89.3); aRT: 82.7Ā % (95Ā % CI 79.3ā85.5); HRĀ =Ā 1.18 (95Ā % CI 0.93ā1.51), pĀ =Ā 0.18 | ALND: 4/744 aRT: 7/681; 5-year: ALND: 0.43Ā % (95Ā % CI 0ā0.92); aRT: 1.19Ā % (95Ā % CI 0.31ā2.08) | None of the studies reported local, regional, locoregional or distant breast cancer recurrence |
OTOASOR | No significant difference, although no overall rates reported | ALND: 94.3Ā % aRT: 97Ā %; non-significant | ALND: 0.82Ā % aRT: 1.3Ā %; non-significant |